1. Selective detection of phosphatidylethanol homologues in blood as biomarkers for alcohol consumption by LC-ESI-MS/MS
- Author
-
Gnann, H., Weinmann, W., Engelmann, C., Wurst, F. M., Skopp, G., Winkler, M., Thierauf, A., Auwärter, V., Dresen, S., and Bouzas, N. Ferreirós
- Abstract
A new validated method for the quantitation of the abnormal phospholipid phosphatidylethanol PEth—a biomarker for ethanol uptake—has been developed by LCESIMSMS following miniaturised organic solvent extraction and reversed phase chromatography with phosphatidylbutanol PBut as internal standard. PEth homologues with two fatty acid substituents—PEth 18 : 118 : 1, PEth 16 : 016 : 0—were determined in postmortem blood collected from heavy drinkers at autopsy and also in whole blood samples from a volunteer after a single 60 gdose of ethanol. Furthermore, PEth 18 : 116 : 0 or its isobaric isomer PEth—16 : 018 : 1 was detected. In comparison to previous highperformance liquid chromatography HPLC methods with evaporative light scattering detection ELSD, the LCMSMSmethod is more sensitive—with a limit of detection below 20 ngml—and more selective for single PEth homologues, while ELSD has been used for detection of the sum of PEth homologues with approximately 10 times less sensitivity. LCMSMS enables monitoring of PEth homologues as biomarkers for harmful and prolonged alcohol consumption as with HPLCELSD earlier, where PEth is measurable in blood only after more than 50 g ethanol daily intake for more than 2 weeks. Because of its higher sensitivity, there is a potential to detect single heavy drinking by LCMSMS, when PEth is formed in very low concentrations. This opens a new field of application of PEth to uncover single or multiple heavy drinking at a lower frequency and with a larger window of detection in blood than before by HPLCELSD or by use of other direct markers, e.g. ethyl glucuronide or ethyl sulfate. Copyright © 2009 John Wiley & Sons, Ltd.
- Published
- 2009
- Full Text
- View/download PDF